(Q44258281)

1 December 2017

title

Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis (English)

1 reference

cost-effectiveness analysis

1 December 2017

0 references

1 reference

based on heuristic

inferred from title

acute coronary syndrome

1 reference

4

1 reference

1 December 2017

6

1 reference

1 December 2017

A Lala

1

1 reference

1 December 2017

J S Berger

series ordinal

2

1 reference

1 December 2017

G Sharma

series ordinal

3

1 reference

1 December 2017

R Scott Braithwaite

series ordinal

5

1 reference

1 December 2017

publication date

1 January 2013

1 reference

Journal of Thrombosis and Haemostasis

1 December 2017

published in

1 reference

1 December 2017

volume

11

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

81-91

1 reference

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 December 2017

cites work

1 reference

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 January 2018

1 reference

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability

21 January 2018

1 reference

The worry about clopidogrel "nonresponsiveness": identification and treatment in the post-percutaneous coronary intervention patient

21 January 2018

1 reference

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis

21 January 2018

1 reference

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

21 January 2018

1 reference

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

21 January 2018

1 reference

ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association

21 January 2018

1 reference

Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transport

21 January 2018

1 reference

Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System

21 January 2018

1 reference

Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry).

21 January 2018

1 reference

Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

21 January 2018

1 reference

The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone

21 January 2018

1 reference

Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery

21 January 2018

1 reference

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes

21 January 2018

1 reference

The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and [...]

21 January 2018

1 reference

Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly

21 January 2018

1 reference

21 January 2018

1 reference

Preference-Based EQ-5D index scores for chronic conditions in the United States

21 January 2018

1 reference

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

21 January 2018

1 reference

Clopidogrel poor metabolizers may need alternative to standard regimen

21 January 2018

1 reference

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

21 January 2018

1 reference

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

21 January 2018

1 reference

Effects of CYP2C19 genotype on outcomes of clopidogrel treatment

21 January 2018

1 reference

CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis

21 January 2018

1 reference

Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial

21 January 2018

1 reference

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement

21 January 2018

1 reference

Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis

21 January 2018

1 reference

Medicare beneficiaries' costs of care in the last year of life

21 January 2018

1 reference

Medical expenditures during the last year of life: findings from the 1992-1996 Medicare current beneficiary survey

21 January 2018

1 reference

Trends in medical spending by age, 1963-2000.

21 January 2018

1 reference

Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTH.12059

1 reference

1 December 2017

1 reference